Always the most comprehensive resource, the MORL expands clinical MLPA, ADAMTS-13 and Classical Pathway Testing. Click PDF iconhere for details.
MORL: A Clinical Revolution - At the Forefront of Precision Medicine for Hearing Impairment  (video)
MORL: The Cutting Edge of Research - Revolutionizing Genetic Research for Hearing Loss  (video)
Unraveling the Mystery in Our Genes (Article)

Featured Content

  • Providing the most accurate clinically-driven interpretation of genetic variants in a timely manne
    Uncontrolled complement activity drives many diseases including two ultra-rare renal diseases. MORL provides a metric to follow a patient’s clinical course. MORL Clinical Testing Menu
  • Providing the most accurate clinically-driven interpretation of genetic variants in a timely manner MORL Clinical Diagnostic Services
  • The Molecular Otolaryngology and Renal Research Laboratory (MORL) is a CLIA approved, Joint Commission accredited diagnostic laboratory with a technical expertise in clinical genetic testing and interpretation. MORL Certifications and Licensure
  • What does it mean to get your testing done at the MORL? Testing at MORL
  • Working to increase our knowledge base of non-syndromic hearing loss and complement-mediated renal disease, including the development of new treatment options for both hearing loss, aHUS and C3G. Research at MORL

MORL Full Testing Menu

What does it mean to get your testing done at the MORL?

  • Your results are discussed at a multidisciplinary meeting.
  • Your testing is done in the Clinical Division of the MORL by scientists who lead the world in the human genetics of deafness and complement-mediated renal diseases.
  • Our testing is the most comprehensive clinical testing available.

OtoSCOPE group3

The Women of the MORL

Research Portal

 

Conferences                     

14th DDD/C3G Family Conference: October 5, 2019
OtoSCOPE
TMA thumb
complement testing

Genetic Hearing Loss

Genetic Renal Panel

Complement Tests
OtoSCOPE provides comprehensive genetic testing for all genes implicated in non-syndromic hearing loss and many types of syndromic hearing loss. An Usher Syndrome Panel is also available. The Genetic Renal Panel tests for genetic causes of TMA (aHUS and TTP) and C3G (DDD and C3GN). The Panel includes analysis for complex genomic rearrangements of the CFHR region. Comprehensive complement testing includes quantitating complement proteins and their cleavage products, measuring complement activity, and screening for autoantibodies.

MORL logo

Helping To Make Lives Better (Videos)

The University of Iowa
285 Newton Rd., 5270 CBRB
Iowa City, IA 52242
Phone: 319-335-6623
Fax: 319-353-5869
Email: morl@uiowa.edu
Follow us: